To verify whether blocking BMP receptor signaling might be a potential strategy for targeted therapy of PCC, we treated MTT cells (high endogenous Bmp7 levels) with DMH1 and then assessed cell proliferation and migration. Here, BMP7 is linked to adrenal gland pheochromocytoma.